ConductScience.org, home

Paper3530295

The mechanism of action of calcium antagonists relative to their clinical applications.

Singh BN. Br J Clin Pharmacol, 1986. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. The mechanism of action of calcium antagonists relative to their clinical applications. Papers, record 3530295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3530295

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The mechanism of action of calcium antagonists relative to their clinical applications.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
3.3
iCite
Revised in PubMed
2019-05-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Singh BNB N

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calcium Channel BlockersMajor topic
Animals
Cardiovascular Diseases
Humans

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16499147Dynamic mechanisms in human coronary stenosis.Circulation1984https://conductscience.org/library/papers/6499147PubMed
23881913Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.Am J Cardiol1985https://conductscience.org/library/papers/3881913PubMed
33155893Second-generation calcium antagonists: search for greater selectivity and versatility.Am J Cardiol1985https://conductscience.org/library/papers/3155893PubMed
43872052Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil.Am J Cardiol1985https://conductscience.org/library/papers/3872052PubMed
56782480A controlled trial of verapamil for Prinzmetal's variant angina.N Engl J Med1981https://conductscience.org/library/papers/6782480PubMed
66267926Verapamil in chronic stable angina: amelioration of pacing-induced abnormalities of left ventricular ejection fraction, regional wall motion, lactate metabolism and hemodynamics.Am J Cardiol1981https://conductscience.org/library/papers/6267926PubMed
76141044Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.Drugs1984https://conductscience.org/library/papers/6141044PubMed
87051136Electrophysiologic and hemodynamic effects of slow-channel blocking drugs.Prog Cardiovasc Dis1982https://conductscience.org/library/papers/7051136PubMed
96338383Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.N Engl J Med1983https://conductscience.org/library/papers/6338383PubMed
106339197Calcium antagonists. Clinical use in the treatment of arrhythmias.Drugs1983https://conductscience.org/library/papers/6339197PubMed
116347970Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine.Headache1983https://conductscience.org/library/papers/6347970PubMed
126362386Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients.Am J Cardiol1984https://conductscience.org/library/papers/6362386PubMed
137044084
Comparative effects of oral verapamil and propranolol on exercise-induced myocardial ischemia and energetics in patients with coronary artery disease: single-blind placebo crossover evaluation using radionuclide ventriculography.
Am Heart J1982https://conductscience.org/library/papers/7044084PubMed

Download CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
37975597Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.Cochrane Database Syst Rev2023https://conductscience.org/library/papers/37975597PubMed
29998494Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29998494PubMed
26747332A trial for the design and optimization of pH-sensitive microparticles for intestinal delivery of cinnarizine.Drug Deliv Transl Res2016https://conductscience.org/library/papers/26747332PubMed
25569258In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni.PLoS Negl Trop Dis2015https://conductscience.org/library/papers/25569258PubMed
24407539The fourth-generation Calcium channel blocker: cilnidipine.Indian Heart J2013https://conductscience.org/library/papers/24407539PubMed
23662062Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension.Vasc Health Risk Manag2013https://conductscience.org/library/papers/23662062PubMed
19771169Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.PLoS One2009https://conductscience.org/library/papers/19771169PubMed
15777109Pharmacologic treatment of chronic pediatric hypertension.Paediatr Drugs2005https://conductscience.org/library/papers/15777109PubMed
11986907Update on the use of calcium antagonists on hypertension.J Hum Hypertens2002https://conductscience.org/library/papers/11986907PubMed
7819013Treatment of hypertension in children.Pediatr Nephrol1994https://conductscience.org/library/papers/7819013PubMed
3065058
Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Drugs1988https://conductscience.org/library/papers/3065058PubMed
3042360Drug treatment of hypertension.Drugs1988https://conductscience.org/library/papers/3042360PubMed
3042243Pharmacokinetics of calcium antagonists under development.Clin Pharmacokinet1988https://conductscience.org/library/papers/3042243PubMed
2150639Isradipine dose-confirmation study in Filipino patients with mild to moderate hypertension.Drugs1990https://conductscience.org/library/papers/2150639PubMed
1804649Non invasive study of systemic and regional haemodynamic and cardiac effects of a new calcium antagonist, SR 33557, in healthy volunteers.Eur J Clin Pharmacol1991https://conductscience.org/library/papers/1804649PubMed
1712708Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.Drugs1991https://conductscience.org/library/papers/1712708PubMed
1385750Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol.Br J Pharmacol1992https://conductscience.org/library/papers/1385750PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3530295

GET https://conductscience.org/api/papers/v1/3530295/authors